



1371 Thermo-wrap technology preserves normothermia better than routine
thermal care in patients undergoing off-pump coronary artery bypass and is
associated with lower immune response and lesser myocardial damage
Nahum Nesher, MD, Gideon Uretzky, MD, Steven Insler, MD, Patrick Nataf, MD,
Inna Frolkis, MD, PhD, Emmanuelle Pineau, MD, Emmanuel Cantoni, MD, Gil Bolotin, MD,
Moshe Vardi, MD, Dimitry Pevni, MD, Oren Lev-Ran, MD, Ram Sharony, MD, and
Avi A.Weinbroum, MD, Tel Aviv, Israel, Cleveland, Ohio, and Paris, France
We assessed the efficacy of a thermo-wrap technique versus routine thermal care in patients
undergoing OPCAB. Almost all patients in the thermo-wrap group achieved perioperative
normothermia (36°C). They had a lower inflammatory response, lesser myocardial damage,
and better cardiovascular performance than the patients who received routine thermal care.
1379 Long-term pulmonary function after thoracic sympathectomy
Miguel A. Ponce González, MD, Gabriel Julià Serdà, MD, Norberto Santana Rodríguez, MD,
Pedro Rodríguez Suárez, MD, Gregorio Pérez Peñate, MD, Jordi Freixinet Gilart, MD, and
Pedro Cabrera Navarro, MD, Las Palmas de Gran Canaria, Spain
Thoracic sympathectomy results in a partial sympathetic pulmonary denervation. The purpose
of this study was to assess the influence of the sympathetic nervous system on pulmonary
function. We conclude that thoracic sympathectomy generates a mild, but significant,
impairment of the bronchomotor tone, with no clinical consequences.
1383 Comparing the global mRNA expression profile of human atrial and
ventricular myocardium with high-density oligonucleotide arrays
Peter Ellinghaus, PhD, Robert J. Scheubel, MD, Dobromir Dobrev, MD, Ursula Ravens, MD,
Juergen Holtz, MD, Joachim Huetter, MD, Ulrich Nielsch, PhD, and Henning Morawietz, PhD,
Wuppertal, Halle-Wittenberg, and Dresden, Germany
In this study, specific gene expression profiles were identified in human LA and LV
myocardium. The data provide the basis of a comprehensive understanding of chamber-specific
gene expression in diseased human hearts and will support the identification of therapeutic
targets in the treatment of arrhythmia and heart failure.
1391 Assessment of hemostatic activation during cardiopulmonary bypass for
coronary artery bypass grafting with bivalirudin: Results of a pilot study
Andreas Koster, MD, Ruhi Yeter, MD, Semih Buz, MD, Hermann Kuppe, MD,
Roland Hetzer, MD, A. Michael Lincoff, MD, Cornelius M. Dyke, MD,
Nicholas G. Smedira, MD, and Bruce Spiess, MD, Berlin, Germany; Cleveland, Ohio;
Gastonia, NC; and Richmond, Va
With our protocol for bivalirudin, hemostatic activation during CPB is almost completely
attenuated if cardiotomy suction is avoided. However, significant hemostatic activation is
observed if cardiotomy suction is used. Therefore, aspiration of blood from the surgical field in
the bypass circuit should be restricted whenever possible and replaced by cell saving when
bivalirudin is used for anticoagulation of CPB. This may limit the feasibility of this agent for
certain procedures in which excessive cardiotomy suction is mandatory.
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